Open AccessThe prevalence of chronic pancreatitis in patients with the first diagnosed pulmonary tuberculosis
Author(s) -
Л.Д. Тодоріко,
Ihor Semianiv
Publication year - 2017
Publication title -
vestnik kluba pankreatologov
Language(s) - English
Resource type - Journals
ISSN - 2077-5067
DOI - 10.33149/vkp.2017.02.08
Subject(s) - medicine , pancreatitis , tuberculosis , comorbidity , incidence (geometry) , adverse effect , pulmonary tuberculosis , lesion , intensive care medicine , gastroenterology , surgery , pathology , physics , optics
Despite the reduction in the incidence of tuberculosis, the side effects of antimycobacterial drugs limit the conduction of a complete chemotherapy. They often develop upon comorbid pancreatic lesion.
Analysis has shown that chronic pancreatitis is observed in 22.2% of cases. It is found that lesions of the pancreas occur 1.7 times more often in patients with resistant forms of tuberculosis than in patients with more sensitive forms.
Lack of proper attention to comorbidity from hepato-pancreatic-biliary system leads to the development of adverse reactions to tuberculosis treatment, which in the future may lead to a temporary cancellation of antituberculous drugs, development of drug resistance and ineffective treatment.